Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June

Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women

PDF) Clinical Impact of Polygenic Risk Score for Breast Cancer Risk Prediction in 382 Individuals with Hereditary Breast and Ovarian Cancer Syndrome

Gene panel screening for insight towards breast cancer susceptibility in different ethnicities

A multi-gene panel beyond BRCA1/BRCA2 to identify new breast cancer-predisposing mutations by a picodroplet PCR followed by a next-generation sequencing strategy: a pilot study - ScienceDirect

BREAST CANCER. END OF ERA FOR BRCA1 / 2 AND NGS PANELS. NEW ERA with POLYGENIC RISK SCORE

Mutational signatures for breast cancer diagnosis using artificial intelligence, Journal of the Egyptian National Cancer Institute

Managing breast cancer in younger women: challenges and solutions

Definition of Breast Cancer Genes for Panel Testing - NCI

Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy - Rizzolo - 2019 - International Journal of Cancer - Wiley Online Library

Familial Cancer Testing - Specialist Pathway

Interpreting Cancer Genetic Testing Results (CME)

About the Multi-Gene Panel Test for Hereditary Breast and Ovarian Cancer

Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in Pakistan

Breast Cancer and Next-Generation Sequencing: Towards Clinical Relevance and Future